阿联酋批准国家基因组总体规划：90万名参与者2026年12月起可查个人基因报告
阿布扎比王储、阿布扎比执行委员会主席 Khaled bin Mohamed 11月11日在阿联酋基因组委员会会议上批准《2026至2031年国家基因组总体规划》，为阿联酋的基因组研究与精准医疗定下下一阶段方向。
会议回顾了「阿联酋基因组计划」的进展：参与人数已经达到100万，是全球覆盖面最广的人群基因组计划之一。总体规划包括四项重点工作：把计划扩大到覆盖全体阿联酋公民、向90万名参与者出具个人基因报告、把新生儿基因筛查推广到全国、强化供国内外医疗机构研究合作使用的可信研究环境。
个人基因报告将自2026年12月起通过 TAMM 平台向参与者提供，内容涵盖214种遗传性基因状况与健康特征，并执行严格的隐私与数据保密标准。
（来源：阿联酋通讯社）
UAE Approves National Genomics Masterplan: Personal Reports for 900,000 Participants From December 2026
Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of the Abu Dhabi Executive Council, approved the 2026-2031 National Genomics Masterplan at a meeting of the Emirates Genome Council on November 11, setting the next phase of genomic research and precision healthcare in the United Arab Emirates.
The meeting reviewed the progress of the Emirati Genome Programme, whose participation has reached one million, making it one of the world's most comprehensive population genome programmes. The masterplan has four priorities: expanding the programme to cover all Emirati citizens, issuing personalized genomic reports to 900,000 participants, extending newborn genetic screening nationwide, and strengthening the Trusted Research Environment that supports research partnerships with local and international healthcare institutions.
The personalized reports will be available to participants through the TAMM platform from December 2026, covering 214 inherited genomic conditions and health traits, under strict privacy and data confidentiality standards.
(Source: WAM)
来源：阿联酋通讯社
发布：GSM·美国（发布链接）
图片来源：图：阿布扎比天际线（资料图）。照片：CC BY-SA 4.0，经维基共享资源 / The Abu Dhabi skyline (file photo). Photo: CC BY-SA 4.0, via Wikimedia Commons
GSM Global · 本篇英文版 English edition of this story
